ROD-188
From Wikipedia, the free encyclopedia
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
IUPAC name
| |
PubChem CID | |
ChemSpider | |
Chemical and physical data | |
Formula | C20H21NO4S |
Molar mass | 371.45 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
ROD-188 is a sedative drug that was structurally derived from the GABAA antagonist bicuculline by a team at Roche.[1] Unlike bicuculline, ROD-188 acts as an agonist at GABAA receptors, being a positive allosteric modulator acting at a novel binding site distinct from those of benzodiazepines, barbiturates or muscimol, with its strongest effect produced at the α6β2γ2 subtype of the GABAA receptor.[2] ROD-188 is one of a number of related compounds acting at this novel modulatory site, some of which also act at benzodiazepine receptors.[3][4]
See also[]
- Bicuculline
References[]
- ^ US Patent 6649626 N-substituted 1-(lactone) isoquinolones for treating nervous disorders
- ^ Thomet U, Baur R, Razet R, Dodd RH, Furtmüller R, Sieghart W, Sigel E (October 2000). "A novel positive allosteric modulator of the GABA(A) receptor: the action of (+)-ROD188". British Journal of Pharmacology. 131 (4): 843–50. doi:10.1038/sj.bjp.0703558. PMC 1572371. PMID 11030736.
- ^ Sigel E, Baur R, Furtmueller R, Razet R, Dodd RH, Sieghart W (June 2001). "Differential cross talk of ROD compounds with the benzodiazepine binding site". Molecular Pharmacology. 59 (6): 1470–7. doi:10.1124/mol.59.6.1470. PMID 11353808.
- ^ Ramerstorfer J, et al. The GABAA Receptor α+β− Interface: A Novel Target for Subtype Selective Drugs. Journal of Neuroscience 2011; 31(3):870-877. doi:10.1523/JNEUROSCI.5012-10.2011
Hypnotics/sedatives (N05C) | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GABAA |
| ||||||||||||||||||||||||
GABAB |
| ||||||||||||||||||||||||
H1 |
| ||||||||||||||||||||||||
α2-Adrenergic |
| ||||||||||||||||||||||||
5-HT2A |
| ||||||||||||||||||||||||
Melatonin |
| ||||||||||||||||||||||||
Orexin |
| ||||||||||||||||||||||||
α2δ VDCC |
| ||||||||||||||||||||||||
Others |
|
GABAA receptor positive modulators | |
---|---|
Alcohols |
|
Barbiturates |
|
Benzodiazepines |
|
Carbamates |
|
Flavonoids |
|
Imidazoles |
|
Kava constituents |
|
Monoureides |
|
Neuroactive steroids |
|
Nonbenzodiazepines |
|
Phenols |
|
Piperidinediones |
|
Pyrazolopyridines |
|
Quinazolinones |
|
Volatiles/gases |
|
Others/unsorted |
|
See also: Receptor/signaling modulators • GABA receptor modulators • GABA metabolism/transport modulators |
GABA receptor modulators | |||||
---|---|---|---|---|---|
Ionotropic |
| ||||
Metabotropic |
| ||||
|
This sedative-related article is a stub. You can help Wikipedia by . |
- v
- t
Retrieved from ""
Categories:
- Drugs not assigned an ATC code
- Sedatives
- Tetrahydroisoquinolines
- Tetrahydrofurans
- Furanones
- GABAA receptor positive allosteric modulators
- GABAA-rho receptor negative allosteric modulators
- P-Tosyl compounds
- Sulfonamides
- Sedative stubs
Hidden categories:
- Drugs with non-standard legal status
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugboxes which contain changes to watched fields
- All stub articles